Intrexon reported $1.35B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Agenus AGEN:US $ 1.22B 664.46M
Amgen AMGN:US $ 140.05B 3.22B
Anika Therapeutics ANIK:US $ 623M 38.49M
Arrowhead Research ARWR:US $ 8.62B 1.74B
AstraZeneca AZN:LN 113.99B 18.86B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Chemocentryx CCXI:US $ 933.95M 2.64B
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
Gilead Sciences GILD:US $ 86.36B 4.99B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Immunogen IMGN:US $ 1.32B 300.21M
Intrexon XON:US $ 1.35B 76.37M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Ligand Pharmaceuticals LGND:US $ 2.18B 347.98M
Macrogenics MGNX:US $ 1.62B 176.65M
Mannkind MNKD:US $ 1.36B 384.05M
Merk MRK:US $ 196918.18M 1780.24M
Novartis NOVN:VX 208.02B 8.76B
Peregrine Pharmaceuticals PPHM:US $ 1.57B 458.25M
Rigel Pharmaceuticals RIGL:US $ 738.51M 156.7M
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Thermo Fisher Scientific TMO:US $ 198.27B 18.91B
Veracyte VCYT:US $ 2.69B 912.75M
Xencor XNCR:US $ 2.01B 489.02M
YTE INCY:US $ 18.5B 632.77M
Ziopharm Oncology ZIOP:US $ 568.99M 205.75M